Navigation Links
Amedica's Silicon Nitride Ceramic Bearing Technology Receives Prestigious HAP Paul Award for Use in Total Hip Arthroplasty
Date:10/10/2007

SALT LAKE CITY, Oct. 10 /PRNewswire/ -- Amedica Corporation, an orthopedic implants company focused on silicon nitride ceramic technologies, announced today that a paper it presented on the in-vitro testing and evaluation of its silicon nitride ceramic bearings for total hip arthroplasty won the HAP Paul Award from the International Society for Technology in Arthroplasty (ISTA). The prestigious HAP Paul Award, which was presented to Amedica at ISTA's 20th Annual Congress, held October 4 - 6, 2007, in Paris, France, is given for outstanding research in new technology for joint replacements.

The award-winning research paper, "In Vitro Performance of Silicon Nitride Ceramic in Total Hip Bearings," will be published by ISTA as a special article in the Journal of Arthroplasty. The paper demonstrates that Amedica's MC2(TM) silicon nitride based ceramic bearings, being developed for reconstructive hip, knee and spine implants, have the combination of strength, toughness and wear resistance characteristics that may overcome the limitations of currently available bearings.

The paper was authored by a team led by Ashok Khandkar, Ph.D., and included B. Sonny Bal, MD, University of Missouri, Columbia; Dr. Aaron A. Hofmann MD; University of Utah; Dr. Ian C. Clarke, Ph.D., Loma Linda University; Dr. Alan Lakshminarayanan, Ph.D., Amedica; and Mohamed N. Rahaman, Ph.D., University of Missouri-Rolla.

The team of collaborators compared the fracture strength and in-vitro wear characteristics using hip simulators of Amedica's Micro-composite Ceramic, or MC2, bearings with current state-of-the-art bearings. The data presented at ISTA's Annual Congress demonstrated that the silicon nitride femoral heads had substantially greater burst strength than similar 28 mm femoral heads made using the strongest commercially available ceramic.

"We are delighted and honored to win the HAP Paul Award for our work," said Ashok Khandkar, Ph.D., CEO of Amedica Corporation. "This paper demonstrates the inherent strength and wear resistance advantages of silicon nitride ceramics compared with the current generation of ceramic orthopedic implants. We are pleased that a group of our peers has selected our research on silicon nitride ceramic and recognized the important potential of this material for total hip arthroplasty. Importantly, we believe independent recognition such as this award, will increase awareness of silicon nitride and support its future use in orthopedic applications such as ceramic bearings for joint replacement."

About Amedica

Amedica Corporation is an emerging orthopedic implants company focused on using its ceramics technologies to develop and commercialize a broad range of innovative, high-performance spine and joint implants for the growing orthopedic device market. Its products under development include reconstructive spine, hip and knee implants that may represent a new standard of care in total joint implants based on superior durability, performance and safety.

Contact:

Ashok C. Khandkar

Chief Executive Officer

(801) 583-5100

Email: ak@amedicacorp.com

http://www.amedicacorp.com


'/>"/>
SOURCE Amedica Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Silicon eye implants
2. Artificial silicon retina
3. Implantable devices to be powered by organosilicon compounds in the future
4. Silicone Rubber Flap Restore Speech
5. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
6. Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants
7. Silicone Leaks Seen Among Women with Breast Implants
8. Canadian Regulators allow Silicone Breast Implants in Market
9. FDA gives the green signal for silicone breast implants
10. School atmosphere have some bearing on bad habits in children
11. Vitamin B: Vital for Women During Child-bearing Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
Breaking Medicine Technology: